Chondroprotective effect of intraarticular injections of interleukin-1 receptor antagonist in experimental osteoarthritis: Suppression of collagenase-1 expression

Arthritis and Rheumatism

Volumn 39, Issue 9, 1996, Pages 1535-1544

  Caron, John P ^a   Fernandes, Julio C ^a   Martel Pelletier, Johanne ^a   Tardif, Ginette ^a   Mineau, François ^a   Geng, Changshan ^a   Pelletier, Jean Pierre ^a  

^a NOTRE DAME HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGENASE; MESSENGER RNA; METALLOPROTEINASE; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; SODIUM CHLORIDE; STROMELYSIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTERIOR CRUCIATE LIGAMENT; ARTICLE; CHONDROPATHY; CONTROLLED STUDY; DOG; DOSE RESPONSE; FEMALE; FEMUR CONDYLE; INTRAARTICULAR DRUG ADMINISTRATION; MALE; NONHUMAN; OSTEOARTHRITIS; PRIORITY JOURNAL; SYNOVIUM;

EID: 0029814957     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.1780390914     Document Type: Article

References (47)

1. Pelletier JP, Howell DS: Etiopathogenesis of osteoarthritis. In, Arthritis and Allied Conditions: A Textbook of Rheumatology. Twelfth edition. Edited by DJ McCarthy, WJ Koopman. Philadelphia, Lea and Febiger, 1993
2. Dean DD: Proteinase-mediated cartilage degradation in osteoarthritis. Semin Arthritis Rheum 20:2-11, 1991
3. Pelletier JP, DiBattista JA, Roughley P, McCollum R, Martel-Pelletier J: Cytokines and inflammation in cartilage degradation. In, Osteoarthritis: Edition of Rheumatic Disease Clinics of North America. Edited by RW Moskowitz. Philadelphia, WB Saunders, 1993
4. Pelletier JP, McCollum R, Cloutier JM, Martel-Pelletier J: Synthesis of metalloproteases and IL-6 in human osteoarthritic synovial membrane in an IL-1 mediated process. J Rheumatol 22:109-114, 1995
5. Larrick JW, Kunkel SL: The role of tumor necrosis factor and interleukin 1 in the immune-inflammatory response. Pharmacol Res 5:129-139, 1988
6. Goldring MB, Birkhead J, Sandell LJ, Kimura T, Krane SM: Interleukin 1 suppresses expression of cartilage-specific types II and IX collagens and increases types I and III collagens in human chondrocytes. J Clin Invest 82:2026-2037, 1988
7. Tyler JA: Articular cartilage cultured with catabolin (pig interleukin 1) synthesizes a decreased number of normal proteoglycan molecules. Biochem J 227:869-878, 1985
8. Dingle JT, Horner A, Shield M: The sensitivity of synthesis of human cartilage matrix to inhibition by IL-1 suggests a mechanism for the development of osteoarthritis. Cell Biochem Funct 9:99-102, 1991
9. Arend WP, Joslin FG, Massoni RJ: Effects of immune complexes on production by human monocytes of interleukin 1 or an interleukin 1 inhibitor. J Immunol 134:3868-3875, 1985
10. 2 and collagenase production by fibroblasts and synovial cells is regulated by urine-derived human interleukin 1 and inhibitor(s). J Clin Invest 78:1120-1124, 1986
11. Carter DB, Deibel MR Jr, Dunn CJ, Tomich CS, Laborde AL, Slightom JL, Berger AE, Bienkowski MJ, Sun FF, McEwan RN, Harris PKW, Yem AW, Waszak GA, Chosay JG, Sieu LC, Hardee MM, Zurcher-Neely HA, Reardon IM, Heinrikson RL, Truesdell SE, Shelly JA, Eessalu TE, Taylor BM, Tracey DE: Purification, cloning, expression and biological characterization of an interleukin-1 receptor antagonist protein. Nature 344:633-638, 1990
12. Hannum CH, Wilcox CJ, Arend WP, Joslin FG, Dripps DJ, Heimdal PL, Armes LG, Sommer A, Eisenberg SP, Thompson RC: Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor. Nature 343:336-340, 1990
13. Smith RJ, Chin JE, Sam LM, Justen JM: Biologic effects of an interleukin-1 receptor antagonist protein on interleukin-1-stimulated cartilage erosion and chondrocyte responsiveness. Arthritis Rheum 34:78-83, 1991
14. Arend WP: Interleukin-1 receptor antagonist. Adv Immunol 54: 167-227, 1993
15. Arend WP, Welgus HG, Thompson RC, Eisenberg SP: Biological properties of recombinant human monocyte-derived interleukin 1 receptor antagonist. J Clin Invest 85:1694-1697, 1990
16. Evans CH, Robbins PD: The interleukin-1 receptor antagonist and its delivery by gene transfer. Receptor 4:9-15, 1994
17. Firestein GS, Berger AE, Tracey DE, Chosay JG, Chapman DL, Paine MM, Yu C, Zvaifler NJ: IL-1 receptor antagonist protein production and gene expression in rheumatoid arthritis and osteoarthritis synovium. J Immunol 149:1054-1062, 1992
18. Adams MA, Pelletier JP: Canine anterior cruciate ligament transection model of osteoarthritis. In, CRC Handbook of Animal Models for the Rheumatic Diseases. Vol. II. Edited by RA Greenwald, HS Diamond. Boca Raton, FL, CRC Press, 1990
19. Brandt KD, Myers SL, Burr D, Albrecht M: Osteoarthritic changes in canine articular cartilage, subchondral bone, and synovium fifty-four months after transection of the anterior cruciate ligament. Arthritis Rheum 34:1560-1570, 1991
20. Pelletier JP, Faure MP, DiBattista JA, Wilhelm S, Visco D, Martel-Pelletier J: Coordinate synthesis of stromelysin, interleukin-1, and oncogene proteins in experimental osteoarthritis: an immunohistochemical study. Am J Pathol 142:95-105, 1993
21. Yu LP Jr, Smith GN Jr, Brandt KD, Myers SL, O'Connor BL, Brandt DA: Reduction of the severity of canine osteoarthritis by prophylactic treatment with oral doxycycline. Arthritis Rheum 35:1150-1159, 1992
22. Pelletier J-P, Mineau F, Raynauld J-P, Woessner JF Jr, Gunja-Smith Z, Martel-Pelletier J: Intraarticular injections with methylprednisolone acetate reduce osteoarthritic lesions in parallel with chondrocyte stromelysin synthesis in experimental osteoarthritis. Arthritis Rheum 37:414-423, 1994
23. Pelletier JP, DiBattista JA, Raynauld JP, Wilhelm S, Martel-Pelletier J: The in vivo effects of intraarticular corticosteroid injections on cartilage lesions, stromelysin, interleukin-1 and oncogene protein synthesis in experimental osteoarthritis. Lab Invest 72:578-586, 1995
24. Mankin HJ, Dorfman H, Lippiello L, Zarins A: Biochemical and metabolic abnormalities in articular cartilage from osteo-arthritic human hips. II. Correlation of morphology with biochemical and metabolic data. J Bone Joint Surg Am 53:523-537, 1971
25. Pelletier J-P, Martel-Pelletier J, Ghandur-Mnaymneh L, Howell DS, Woessner JF Jr: Role of synovial membrane inflammation in cartilage matrix breakdown in the Pond-Nuki dog model of osteoarthritis. Arthritis Rheum 28:554-561, 1985
26. Fernandes JC, Martel-Pelletier J, Otterness IG, Lopez-Anaya A, Mineau F, Tardif G, Pelletier J-P: Effects of Tenidap on canine experimental osteoarthritis: I. morphologic and metalloprotease analysis. Arthritis Rheum 38:1290-1303, 1985
27. Goldberg GI, Wilhelm SM, Kronberger A, Bauer EA, Grant GA, Eisen AZ: Human fibroblast collagenase: complete primary structure and homology to an oncogene transformation-induced rat protein. J Biol Chem 261:6600-6605, 1986
28. Saus J, Quinones S, Otani Y, Nagase H, Harris ED Jr, Kurkinen M: The complete primary structure of human matrix metalloproteinase-3. J Biol Chem 263:6742-6745, 1988
29. Tso JY, Sun XH, Kao TH, Reece KS, Wu R: Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs: genomic complexity and molecular evolution of the gene. Nucleic Acids Res 13:2485-2502, 1985
30. Van den Berg WB, Joosten LA, Helsen M, van de Loo FA: Amelioration of established murine collagen-induced arthritis with anti-IL-1 treatment. Clin Exp Immunol 95:237-243, 1994
31. Van de Loo FA, Arntz OJ, Otterness IG, van den Berg WB: Protection against cartilage proteoglycan synthesis inhibition by antiinterleukin 1 antibodies in experimental arthritis. J Rheumatol 19:348-356, 1992
32. Yodlowski ML, Hubbard JR, Kispert J, Keller K, Sledge CB, Steinberg JJ: Antibody to interleukin 1 inhibits the cartilage degradative and thymocyte proliferative actions of rheumatoid synovial culture medium. J Rheumatol 17:1600-1607, 1990
33. Wooley PH, Whalen JD, Chapman DL, Berger AE, Richard KA, Aspar DG, Staite ND: The effect of an interleukin-1 receptor antagonist protein on type II collagen-induced arthritis and antigen-induced arthritis in mice. Arthritis Rheum 36:1305-1314, 1993
34. Matsukawa A, Ohkawara S, Maeda T, Takagi K, Yoshinaga M: Production of IL-1 and IL-1 receptor antagonist and the pathological significance in lipopolysaccharide-induced arthritis in rabbits. Clin Exp Immunol 93:206-211, 1993
35. Schwab JH, Anderle SK, Brown RR, Dalldorf FG, Thompson RC: Pro- and anti-inflammatory roles of interleukin-1 in recurrence of bacterial cell wall-induced arthritis in rats. Infect Immun 59:4436-4442, 1991
36. Rickard DJ, Gowen M, MacDonald BR: Proliferative responses to estradiol, IL-1 alpha and TGF beta by cells expressing alkaline phosphatase in human osteoblast-like cell cultures. Calcif Tissue Int 52:227-233, 1993
37. Taichman RS, Hauschka PV: Effects of interleukin-1 beta and tumor necrosis factor-alpha on osteoblastic expression of osteocalcin and mineralized extracellular matrix in vitro. Inflammation 16:587-601, 1992
38. Van Beuningen HM, van der Kraan PM, Arntz OJ, van den Berg WB: Transforming growth factor-beta 1 stimulates articular chondrocyte proteoglycan synthesis and induces osteophyte formation in the murine knee joint. Lab Invest 71:279-290, 1994
39. Arend WP: Growth factors and cytokines in the rheumatic diseases. In, Primer on the Rheumatic Diseases. Tenth edition. Edited by HR Schumacher, JH Klippel, WJ Koopman. Atlanta, The Arthritis Foundation, 1993
40. Vivien D, Galera P, Lebrun E, Loyau G, Pujol JP: Differential effects of transforming growth factor-beta and epidermal growth factor on the cell cycle of cultured rabbit articular chondrocytes. J Cell Physiol 143:534-545, 1990
41. 3H] thymidine incorporation by human articular chondrocytes in vitro. Biochim Biophys Acta 1226:193-200, 1994
42. Guerne PA, Sublet A, Lotz M: Growth factor responsiveness of human articular chondrocytes: distinct profiles in primary chondrocytes, subcultured chondrocytes, and fibroblasts. J Cell Physiol 158:476-484, 1994
43. Pujol JP, Galera P, Pronost S, Boumediene K, Vivien D, Macro M, Min W, Redini F, Penfornis H, Daireaux M: Transforming growth factor-beta (TGF-beta) and articular chondrocytes. Ann Endocrinol (Paris) 55:109-120, 1994
44. Nguyen Q, Mort JS, Roughley PJ: Preferential mRNA expression of prostromelysin relative to procollagenase and in situ localization in articular cartilage. J Clin Invest 89:1189-1197, 1992
45. MacNaul KL, Chartrain N, Lark M, Tocci MJ, Hutchinson NI: Discoordinate expression of stromelysin, collagenase, and tissue inhibitor of metalloproteinases-1 in rheumatoid human synovial fibroblasts: synergistic effects of interleukin-1 and tumor necrosis factor-alpha on stromelysin expression. J Biol Chem 265:17238-17245, 1990
46. Arner E, Harris RR, DiMeo TM, Collins RC, Galbraith W: Interleukin-1 receptor antagonist inhibits proteoglycan breakdown in antigen induced but not polycation induced arthritis in the rabbit. J Rheumatol 22:1338-1346, 1995
47. Arend WP, Dayer J-M: Inhibition of the production and effects of interleukin-1 and tumor necrosis factor a in rheumatoid arthritis. Arthritis Rheum 38:151-160, 1995